Redhill Biopharma
RDHL
#10417
Rank
C$7.41 M
Marketcap
C$1.45
Share price
-5.36%
Change (1 day)
-82.62%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: C$7.41 Million

As of February 2026 Redhill Biopharma has a market cap of C$7.41 Million. This makes Redhill Biopharma the world's 10417th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$7.41 M-6.76%
2025C$7.95 M-37.39%
2024C$12.69 M-66.67%
2023C$38.09 M119.42%
2022C$17.36 M-89.92%
2021C$0.17 B-55.63%
2020C$0.38 B38.89%
2019C$0.27 B30.37%
2018C$0.21 B56.01%
2017C$0.13 B-42.67%
2016C$0.23 B5.58%
2015C$0.22 B67.06%
2014C$0.13 B68.06%
2013C$80.89 M

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Redhill Biopharma was reported to be:

C$7.41 Million
by Nasdaq info icon info icon
C$7.41 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
C$159.72 B 2,154,668.15%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$404.26 B 5,453,430.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$157.91 B 2,130,206.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$55.80 B 752,770.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
C$2.20 B 29,699.12%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel